Tamala, Cherry L.
HRN: 09-41-01 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2024
CEFUROXIME 500MG (TAB)
03/22/2024
03/29/2024
PO
500mg
BID X 7 Days
S/P NSVD With RMLE And Repair
Checking Final Appropriateness